Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05725525 · ClinicalTrials.gov registry record · NA
A Study of Internet Delivered Parent Child Interaction Therapy
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05725525: Completed NA study, sponsored by Mayo Clinic.
NCT05725525 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05725525, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about how feasible remote parent child interaction therapy (PCIT) is for children with disruptive behaviors and how to augment treatment with wearable devices.
Primary Outcome
Biometrics from the Garmin watch will be analyzed through Fitabase: step count, activity intensity, calories, heartrate, and respirations. This data will be compared throughout the study to see if factors trend down by the end of the trial. This would indicate that the child's behaviors were calmer at the end of the therapy when compared to the beginning.
Interventions
- BEHAVIORAL Remote PCIT augmented with wearable devices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-03-02 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
What the finished NCT05725525 record still lists
NCT05725525 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Remote PCIT augmented with wearable devices is the first listed.
NCT05725525 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05725525 about?
NCT05725525 is a clinical study titled "A Study of Internet Delivered Parent Child Interaction Therapy". The purpose of this study is to learn more about how feasible remote parent child interaction therapy (PCIT) is for children with disruptive behaviors and how to augment treatment with wearable devices.
What is the current status of trial NCT05725525?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2023-03-02. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT05725525?
The interventions under investigation include: Remote PCIT augmented with wearable devices (BEHAVIORAL).
Who is sponsoring clinical trial NCT05725525?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05725525's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI